Skip to main content
. 2019 Jun 13;8(6):843. doi: 10.3390/jcm8060843

Table 1.

Patients’ clinical characteristics and outcomes.

Variable Lymphocytopenic Patients n = 141 Non-Lymphocytopenic Patients n = 332 p-Value
Age, years 68 (58; 76) 66 (54; 74) 0.13
Sex, male/female, n 99/42 226/109 0.65
Previous corticosteroid use 26 (20) 30 (10) 0.003
SAPS score at ICU admission 40 (29; 50) 38 (29; 48) 0.49
SOFA score at ICU admission 7 (5; 10) 7 (5; 10) 0.88
Lymphocyte counts at ICU admission, cells/mm3 533 (352; 844) 1005 (659; 1382) <0.001
Co-morbidities
Diabetes mellitus 40 (28) 72 (22) 0.12
Chronic renal failure 19 (13) 26 (8) 0.056
Solid cancer 27 (19) 56 (17) 0.55
Chronic heart disorders 50 (35) 111 (33) 0.67
Chronic lung disease 56 (40) 98 (30) 0.030
COPD 38 (27) 64 (19) 0.063
Chronic liver disease 39 (28) 51 (15) 0.002
Main causes of ICU admission:
Post-operative 20 (14) 78 (23) 0.022
Decreased consciousness 17 (12) 40 (12) >0.99
Hypoxemic respiratory failure 29 (21) 53 (16) 0.23
VAP/HAP 80 (57)/ 61 (31) 197 (59)/ 135 (69) 0.60
Severity of pneumonia assessment
SOFA score at day 1 8 (6; 10) 7 (4; 9) 0.003
Multi-lobar involvement 77 (55) 143 (43) 0.021
ARDS criteria 21 (15) 41 (12) 0.47
Shock at onset of pneumonia 69 (49) 135 (41) 0.050
Laboratory variables at onset of pneumonia
Serum creatinine, mg/dL 1 (0.6; 1.7) 0.9 (0.7; 1.4) 0.19
White blood cell count, L−9 10,500 (7000; 14,200) 13,560 (9555; 18,250) <0.001
Lymphocyte counts, cells/mm3 396 (268; 589) 1045 (793; 1431) <0.001
Outcomes
Treatment failure at 72 h 85 (60) 170 (51) 0.070
28-day mortality 38 (27) 59 (18) 0.024
90-day mortality 74 (53) 111 (34) <0.001

Abbreviations: ARDS, acute respiratory distress syndrome; VAP, ventilator-associated pneumonia; COPD, chronic obstructive pulmonary disease; CPIS, clinical pulmonary infection score (only for patients with VAP); ICU, intensive care unit; HAP, hospital-acquired pneumonia; PaO2/FiO2, ratio of partial pressure arterial oxygen to fraction of inspired oxygen; SAPS, simplified acute physiology score; SOFA, sequential organ failure assessment. Data are presented as number of patients (%) or median (1st quartile; 3rd quartile); p-values calculated by Mann–Whitney U test, chi-square test, or Fisher’s exact test. Percentages calculated on non-missing data.